These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7501345)
41. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Palma F; Xholli A; Cagnacci A; Maturitas; 2018 Feb; 108():18-23. PubMed ID: 29290210 [TBL] [Abstract][Full Text] [Related]
42. The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy. Constantine GD; Simon JA; Pickar JH; Archer DF; Kushner H; Bernick B; Gasper G; Graham S; Mirkin S; Menopause; 2017 Apr; 24(4):409-416. PubMed ID: 27922936 [TBL] [Abstract][Full Text] [Related]
43. Sexual function in females after radiotherapy for rectal cancer. Bruheim K; Tveit KM; Skovlund E; Balteskard L; Carlsen E; Fosså SD; Guren MG Acta Oncol; 2010 Aug; 49(6):826-32. PubMed ID: 20615170 [TBL] [Abstract][Full Text] [Related]
44. Indications for gynecologic surgery and their implications for sexual function in menopausal women. Seffah JD; Kwame-Aryee RA; Adanu RM; Munumi K; Awotwi EK Int J Gynaecol Obstet; 2008 Dec; 103(3):203-6. PubMed ID: 18812243 [TBL] [Abstract][Full Text] [Related]
45. Vaginal atrophy across the menopausal age: results from the ANGEL study. Cagnacci A; Xholli A; Sclauzero M; Venier M; Palma F; Gambacciani M; Climacteric; 2019 Feb; 22(1):85-89. PubMed ID: 30601037 [TBL] [Abstract][Full Text] [Related]
46. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive. Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127 [TBL] [Abstract][Full Text] [Related]
47. Comparison of the changes in sexual function of premenopausal and postmenopausal women following transvaginal mesh surgery. Long CY; Hsu CS; Wu MP; Lo TS; Liu CM; Tsai EM J Sex Med; 2011 Jul; 8(7):2009-16. PubMed ID: 21605344 [TBL] [Abstract][Full Text] [Related]
48. Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases. Goldstein AT; King MA Sex Med; 2016 Sep; 4(3):e217-20. PubMed ID: 27373143 [TBL] [Abstract][Full Text] [Related]
49. Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Simon JA; Nappi RE; Kingsberg SA; Maamari R; Brown V Menopause; 2014 Feb; 21(2):137-42. PubMed ID: 23736862 [TBL] [Abstract][Full Text] [Related]
50. Ospemifene: a safe treatment of vaginal atrophy. Del Pup L Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3934-3944. PubMed ID: 27735020 [TBL] [Abstract][Full Text] [Related]
51. Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors. Stinesen Kollberg K; Waldenström AC; Bergmark K; Dunberger G; Rossander A; Wilderäng U; Åvall-Lundqvist E; Steineck G Acta Oncol; 2015 May; 54(5):772-9. PubMed ID: 25761090 [TBL] [Abstract][Full Text] [Related]
52. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial. Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055 [TBL] [Abstract][Full Text] [Related]
53. Predictors of genital pain in young women. Farmer MA; Meston CM Arch Sex Behav; 2007 Dec; 36(6):831-43. PubMed ID: 17674182 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials. Pitsouni E; Grigoriadis T; Douskos A; Kyriakidou M; Falagas ME; Athanasiou S Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():45-56. PubMed ID: 30103082 [TBL] [Abstract][Full Text] [Related]
55. Vaginal changes and sexuality in women with a history of cervical cancer. Bergmark K; Avall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G N Engl J Med; 1999 May; 340(18):1383-9. PubMed ID: 10228188 [TBL] [Abstract][Full Text] [Related]
56. Age of sexual debut and central introital dyspareunia. Donders GG; Folens S; Peperstraete B; Bellen G Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):90-2. PubMed ID: 21703751 [TBL] [Abstract][Full Text] [Related]
57. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. Nappi RE; Kingsberg S; Maamari R; Simon J J Sex Med; 2013 Sep; 10(9):2232-41. PubMed ID: 23809691 [TBL] [Abstract][Full Text] [Related]
58. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Freedman MA Womens Health (Lond); 2014 Jul; 10(4):445-54. PubMed ID: 25259904 [TBL] [Abstract][Full Text] [Related]
59. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341 [TBL] [Abstract][Full Text] [Related]
60. Self-assessment of anatomy, sexual sensitivity, and function of the labia and vagina. Schober JM; Alguacil NM; Cooper RS; Pfaff DW; Meyer-Bahlburg HF Clin Anat; 2015 Apr; 28(3):355-62. PubMed ID: 25683213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]